The estimated Net Worth of Margaret Smith Bell is at least $809 dollars as of 20 August 2020. Ms. Bell owns over 5,391 units of Tonix Pharmaceuticals Corp stock worth over $809 and over the last 6 years she sold TNXP stock worth over $0. In addition, she makes $0 as Independent Director at Tonix Pharmaceuticals Corp.
Margaret has made over 1 trades of the Tonix Pharmaceuticals Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently she bought 5,391 units of TNXP stock worth $5,014 on 20 August 2020.
The largest trade she's ever made was buying 5,391 units of Tonix Pharmaceuticals Corp stock on 20 August 2020 worth over $5,014. On average, Margaret trades about 674 units every 0 days since 2018. As of 20 August 2020 she still owns at least 5,391 units of Tonix Pharmaceuticals Corp stock.
You can see the complete history of Ms. Bell stock trades at the bottom of the page.
Margaret Smith Bell serves as Independent Director of the Company. She became a Director in September 2017. Ms. Bell has been retired for the last ten years. Previously, Ms. Bell was a Vice President at Standard Life Investments where she was a portfolio manager and health care equity analyst. Ms. Bell was also a Managing Director at Putnam Investments, and served as a senior health care analyst and a portfolio manager of the Putnam Health Sciences Trust. Ms. Bell was an analyst and vice president at State Street Research and a research analyst at Alex. Brown & Sons, Inc. Ms. Bell is a past member of the Board of Overseers at Beth Israel Deaconess Medical Center. Ms. Bell holds a B.A. from Wesleyan University and an M.B.A. from the Wharton School at the University of Pennsylvania. Ms. Bell’s extensive healthcare and investment banking experience were instrumental in her selection as a member of the Board.
Margaret Bell is 60, she's been the Independent Director of Tonix Pharmaceuticals Corp since 2017. There are 8 older and 6 younger executives at Tonix Pharmaceuticals Corp. The oldest executive at Tonix Pharmaceuticals Holding Corp is Adeoye Olukotun, 75, who is the Independent Director.
Margaret's mailing address filed with the SEC is C/O TONIX PHARMACEUTICALS HOLDING CORP., 26 MAIN STREET, SUITE 101, CHATHAM, NJ, 07928.
Over the last 12 years, insiders at Tonix Pharmaceuticals Corp have traded over $155,884 worth of Tonix Pharmaceuticals Corp stock and bought 1,820,071 units worth $3,399,062 . The most active insiders traders include Ernest Mario, Seth Lederman и Bruce Daugherty. On average, Tonix Pharmaceuticals Corp executives and independent directors trade stock every 32 days with the average trade being worth of $2,734. The most recent stock trade was executed by Seth Lederman on 29 June 2022, trading 20,000 units of TNXP stock currently worth $34,200.
tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.
Tonix Pharmaceuticals Corp executives and other stock owners filed with the SEC include: